Pfizer: AstraZeneca takeover could lead to R&D and job cuts

Pfizer chief executive Ian Read made the admission when questioned by a parliamentary committee on Tuesday, despite the company’s previous stance that any takeover of AstraZeneca would be positive for the UK. “I’m not sitting here saying that we can become more efficient without some reduction in jobs,” he told MPs on the business select…